Loading, please wait...
Corporate Education
in joint-providership with the University of South Carolina College of Pharmacy
19th Annual Heart Failure Symposium
Wednesday, September 17, 2025
7:30 a.m. – 4:15 p.m.
To register, visit www.spartanburgregional.com/CEEvents (online registration closes after September 12),
or Direct Link: click here!
LOCATION: The Piedmont Club, 361 E. Main St., Spartanburg, South Carolina 29302
FEES: $130 for Pharmacists (Other professions are listed in the Direct Link)
THE PIEDMONT CLUB DRESS CODE
Men: LUNCH Gentlemen are NOT required to wear a jacket. Ties are not required.
Women: Suit (including business pantsuit), dress or blazer with skirt or tailored slacks, tailored pants with a blouse or sweater.
Prohibited: T-Shirts, sweatshirts, or other shirt without collar; athletic attire, tennis shoes, shorts, jeans (regardless of value), denim jackets, untucked shirts, and baseball caps.
Women: Suit (including business pantsuit), dress or blazer with skirt or tailored slacks, tailored pants with a blouse or sweater.
Prohibited: T-Shirts, sweatshirts, or other shirt without collar; athletic attire, tennis shoes, shorts, jeans (regardless of value), denim jackets, untucked shirts, and baseball caps.
PROGRAM LEARNING OBJECTIVES:
(For individual learning objectives, please click on the (+) next to the session you wish to view below).
Upon completion of this program, the participant will be able to:
- Describe the role of echocardiography in the treatment of heart failure
- Discuss the role of the heart team in managing heart failure patients eligible for transcatheter valve therapies
- Explain the role of GLP-1 receptor agonists in the management of heart failure
- Discuss the diagnosis and treatment for ATTR Amyloidosis
- Identify the diagnosis and treatment for pulmonary hypertension and heart failure
- Recognize treatment modalities for RV failure
- Review the impact of patient outcome on referral timing and case studies
AGENDA (schedule is subject to change)
|
7:30 a.m.
|
Registration, Exhibits, Continental Breakfast
|
|
|
7:55
|
Welcome, Introductions
|
|
|
8:00
|
|
Shane Reighard, MD
|
|
8:45
|
|
Kim Valenti, MSN, FNP-C
|
|
9:30
|
Break, Exhibits
|
|
|
9:45
|
|
Caroline Emery, PharmD
|
|
10:45
|
1. Mike Lane
2. Art Still
|
James Ampadu, MD
|
|
12:15 p.m.
|
Lunch (provided), Exhibits
|
|
|
1:15
|
|
Ikenna Onyebueke, MD
|
|
2:00
|
|
Ryan Lapointe, MD
|
|
2:45
|
Break, Exhibits
|
|
|
3:00
|
|
Amanda Green, MSN, AGACNP-BC, FNP-C, APRN
|
|
4:00
|
Wrap-up, Questions, Evaluations
|
|
|
4:15
|
Adjourn
|
|
Date: Sep 17, 2025 07:30 AM - 04:15 PM
Fee
$130.00
CE Hours
6.50
CE Units
0.650
Activity Type
- Knowledge-Based and Application-Based
Target Audience(s)
- Pharmacists
Accreditation(s)
|
The University of South Carolina College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Co-Sponsor(s)
Spartanburg Regional Healthcare System
Requirements for CE Credit
Participants must check in with the front desk upon arrival and have attendance verified. Participants will receive credit for attending this program in its entirety and fully completing the associated evaluation. Failure to complete the evaluation within the specified time period (within 30 days of attendance) may result in loss of credit. The NABP CPE Monitor will reject any credit claimed greater than 60 days from the date of the program.
Participants must update their accounts to properly reflect their month and day of birth and their correct NABP E-Id. Failure to do so may result in loss of credit. Registration with a proper disclosure of your NABP E-Id is a requirement for receiving Continuing Pharmacy Education. To register with or look up your NABP E-Id, please click on the CPE Monitor logo below to be directed to their site:
At the completion of this activity, the participant will be able to:
- Discuss the ACC/AHA recommendations regarding ECHO imaging in heart failure
- Discuss the relevant echocardiographic information for patients being treated for heart failure
- Describe new ECHO technologies that will aide in the diagnosis and treatment of heart failure
Speaker(s)/Author(s)
|
Shane Reighard, MD
|
Activity Number
0062-9999-25-092-L01-P
Date:
09/17/25
Time:
08:00 AM - 08:45 AM
CE Hours
0.75
At the completion of this activity, the participant will be able to:
- Explain the relationship between congestive heart failure and mitral/tricuspid valve regurgitation on heart failure progression
- Identify patients with heart failure who are appropriate candidates for MitraClip or TriClip based on echocardiographic findings and guideline recommendations
- Describe current research and evolving role of transcatheter valve repair in heart failure management
Speaker(s)/Author(s)
|
Kimberly W. Valenti, MSN, APRN, FNP-C
|
Activity Number
0062-9999-25-093-L01-P
Date:
09/17/25
Time:
08:45 AM - 09:30 AM
CE Hours
0.75
At the completion of this activity, the participant will be able to:
- Describe the mechanism of action of GLP-1 receptor agonists and their cardiovascular effects
- Summarize the current clinical evidence supporting the use of GLP-1 receptor agonists in patients with heart failure, with or without diabetes
- Apply guideline-based evidence to optimize therapy in patient cases
Speaker(s)/Author(s)
|
Caroline Emery, PharmD
|
Activity Number
0062-9999-25-094-L01-P
Date:
09/17/25
Time:
09:45 AM - 10:45 AM
CE Hours
1.00
At the completion of this activity, the participant will be able to:
- Discuss the presentation and diagnosis of ATTR amyloidosis
- Identify the patient populations at risk for ATTR amyloidosis
- Discuss treatments for ATTR amyloidosis
Speaker(s)/Author(s)
|
James Ampadu, MD
|
Activity Number
0062-9999-25-095-L01-P
Date:
09/17/25
Time:
10:45 AM - 12:15 PM
CE Hours
1.50
At the completion of this activity, the participant will be able to:
- Differentiate the pathophysiologic mechanisms and classifications of pulmonary hypertension, including the five WHO groups and hemodynamic subtypes
- Identify causes, risk factors, and comorbid conditions associated with the development of pulmonary hypertension
- Recognize clinical signs, symptoms, and diagnostic findings that support the identification of pulmonary hypertension
- Evaluate current treatment strategies for pulmonary hypertension, including general measures and targeted therapies, to support appropriate patient referral and management
Speaker(s)/Author(s)
|
Ikenna Onyebueke, MD, FCCP
|
Activity Number
0062-9999-25-096-L01-P
Date:
09/17/25
Time:
01:15 PM - 02:00 PM
CE Hours
0.75
At the completion of this activity, the participant will be able to:
- Define RV failure
- Recognize RV failure based on clinical exam findings
- Differentiate Septic vs Cardiogenic Shock based on POCUS findings
- Identify treatment modalities for RV failure
Speaker(s)/Author(s)
|
Ryan Lapointe, MD, MS
|
Activity Number
0062-9999-25-097-L01-P
Date:
09/17/25
Time:
02:00 PM - 02:45 PM
CE Hours
0.75
At the completion of this activity, the participant will be able to:
- Identify current gaps in the timing of referrals to heart failure clinics and their impact on patient outcomes across all stages of heart failure
- Recognize the clinical benefits of timely and appropriate referrals to specialized heart failure care, including improved patient management and outcomes
- Apply evidence-based guidelines and best practices to optimize referral timing and decision-making for patients with heart failure
Speaker(s)/Author(s)
|
Amanda Green, MSN, AGACNP-BC, FNP-C
|
Activity Number
0062-9999-25-098-L01-P
Date:
09/17/25
Time:
03:00 PM - 04:00 PM
CE Hours
1.00